SCOPUS 정보 검색 플랫폼

Volumn 39, Issue 1, 1996, Pages 52-56

Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement

(8) Choy, Ernest H S a,c Pitzalis, Costantino a Cauli, Alberto a Bijl, J A b Schantz, Allen b Woody, J b Kingsley, Gabrielle H a Panayi, Gabriel S a

a KING'S COLLEGE LONDON (United Kingdom)

b CENTOCOR INC (United States)

c GUY S HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MONOCLONAL ANTIBODY; OKT 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ARTHRITIS, RHEUMATOID; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DRUG ADMINISTRATION SCHEDULE; HUMANS; MIDDLE AGED; SYNOVIAL FLUID; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030063898 PISSN: 00043591 EISSN: None Source Type: Journal
DOI: 10.1002/art.1780390107 Document Type: Article

Times cited : (59)

References (4)

1
- 0028271154
- Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): Immunopharmacological aspects and mechanisms of action
- Van der Lubbe PA, Reiter C, Miltenburg AM, Kruger K, de Ruyter AN, Rieber EP, Bijl JA, Riethmuller G, Breedveld FC: Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action. Scand J Immunol 39:286-294, 1994
- (1994) Scand J Immunol , vol.39 , pp. 286-294
- Van Der Lubbe, P.A.¹ Reiter, C.² Miltenburg, A.M.³ Kruger, K.⁴ De Ruyter, A.N.⁵ Rieber, E.P.⁶ Bijl, J.A.⁷ Riethmuller, G.⁸ Breedveld, F.C.⁹

2
- 0026656620
- Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody
- Choy EHS, Chikanza IC, Kingsley GH, Corrigall V, Panayi GS: Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody. Scand J Immunol 36:291-298, 1992
- (1992) Scand J Immunol , vol.36 , pp. 291-298
- Choy, E.H.S.¹ Chikanza, I.C.² Kingsley, G.H.³ Corrigall, V.⁴ Panayi, G.S.⁵

3
- 0028238428
- Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody: Long-term followup of CD4+ T cell counts
- Moreland LW, Pratt PW, Bucy RP, Jackson BS, Feldman JW, Koopman WJ: Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody: long-term followup of CD4+ T cell counts. Arthritis Rheum 37:834-838, 1994
- (1994) Arthritis Rheum , vol.37 , pp. 834-838
- Moreland, L.W.¹ Pratt, P.W.² Bucy, R.P.³ Jackson, B.S.⁴ Feldman, J.W.⁵ Koopman, W.J.⁶

4
- 0023945481
- The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunter GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
- (1988) Arthritis Rheum , vol.31 , pp. 315-324
- Arnett, F.C.¹ Edworthy, S.M.² Bloch, D.A.³ McShane, D.J.⁴ Fries, J.F.⁵ Cooper, N.S.⁶ Healey, L.A.⁷ Kaplan, S.R.⁸ Liang, M.H.⁹ Luthra, H.S.¹⁰ Medsger Jr., T.A.¹¹ Mitchell, D.M.¹² Neustadt, D.H.¹³ Finals, R.S.¹⁴ Schaller, J.G.¹⁵ Sharp, J.T.¹⁶ Wilder, R.L.¹⁷ Hunter, G.G.¹⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.